SCHEMBL6598128

SCHEMBL6598128

Nc1cc(C(F)(F)F)c([N+](=O)[O-])cc1C=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
CYP3A4 P08684 5/20 0.38
ALOX15 P16050 4/20 0.38
MAPT P10636 3/20 0.38
KDM4E B2RXH2 1/20 0.38
PRKDC P78527 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CA12 O43570 1/20 0.38
CA9 Q16790 1/20 0.38
KIF11 P52732 1/20 0.38
TDP1 Q9NUW8 5/20 0.38
TSHR P16473 3/20 0.38
HPGD P15428 1/20 0.38
HIF1A Q16665 1/20 0.38
TXNRD1 Q16881 1/20 0.38
TXNRD3 Q86VQ6 1/20 0.38
TXNRD2 Q9NNW7 1/20 0.38
ERN1 O75460 2/20 0.37
SIRT6 Q8N6T7 1/20 0.37
LMNA P02545 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29267940 0.78 ALDH1A1 (0.49) ALDH1A1CYP3A4ALOX15MAPTCA12
SCHEMBL979706 0.77 ALDH1A1 (0.47) ALDH1A1CYP3A4ALOX15MAPTCA12
SCHEMBL27706494 0.77 ALDH1A1 (0.48) ALDH1A1CYP3A4ALOX15MAPTCA12
SCHEMBL31451451 0.77 ALDH1A1 (0.47) ALDH1A1CYP3A4ALOX15MAPTCA12
SCHEMBL3240394 0.77 ALDH1A1 (0.57) ALDH1A1CYP3A4ALOX15HSD17B10CA12
SCHEMBL29761562 0.77 ALDH1A1 (0.57) ALDH1A1CYP3A4ALOX15HSD17B10CA12
SCHEMBL6599201 0.76 TDP1 (0.44) ALDH1A1CYP3A4ALOX15MAPTKDM4E
SCHEMBL8903008 0.75 ALDH1A1 (0.53) ALDH1A1CYP3A4ALOX15MAPTTDP1
SCHEMBL31422943 0.75 KIF11 (0.43) CA12CA9KIF11TSHRERN1
SCHEMBL20783115 0.75 ALDH1A1 (0.59) ALDH1A1CYP3A4ALOX15MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1773788-B1 Quinazoline derivatives NOVARTIS AG (CH) 2012-11-14 EP disclosed
EP-1156044-B1 6-SUBSTITUTED HETEROQUINOLINECARBOXYLIC ACID DERIVATIVES AND ADDITION SALTS THEREOF AND PROCESSES FOR THE PREPARATION OF BOTH KYORIN SEIYAKU KK (JP) 2004-08-25 EP disclosed
US-6562839-B1 Effective for the therapy of disorder of cerebral nerve cells as antagonists against excitatory amino acid receptors KYORIN PHARMACEUTICAL CO., LTD. (JP) 2003-05-13 US disclosed
EP-1156044-A1 6-SUBSTITUTED HETEROQUINOLINECARBOXYLIC ACID DERIVATIVES AND ADDITION SALTS THEREOF AND PROCESSES FOR THE PREPARATION OF BOTH KYORIN PHARMACEUTICAL CO., LTD. (JP) 2001-11-21 EP disclosed